ロード中...
Digoxin Use and Subsequent Clinical Outcomes in Patients With Atrial Fibrillation With or Without Heart Failure in the ENGAGE AF‐TIMI 48 Trial
BACKGROUND: Digoxin is widely used in patients with atrial fibrillation despite the lack of randomized controlled trials. Observational studies report conflicting results regarding its association with mortality, perhaps because of residual confounding by the presence of heart failure (HF). METHODS...
保存先:
| 出版年: | J Am Heart Assoc |
|---|---|
| 主要な著者: | , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5586309/ https://ncbi.nlm.nih.gov/pubmed/28666993 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.117.006035 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|